[177Lu]Lu-P17-079

N/A

Report date: 2025/10/30 15:24:45

Base Information

Drug Name[177Lu]Lu-P17-079

Drug Alias Name[177Lu]Lu-P17-079[177Lu]Lu-1

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFive Eleven Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesFive Eleven Pharma Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A